株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

技術的・臨床的ディスラプションの画像診断利用率への影響:2017-2022年

Implications on Utilisation of Diagnostic Imaging, 2017-2022

発行 Frost & Sullivan 商品コード 792022
出版日 ページ情報 英文 140 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
技術的・臨床的ディスラプションの画像診断利用率への影響:2017-2022年 Implications on Utilisation of Diagnostic Imaging, 2017-2022
出版日: 2019年02月06日 ページ情報: 英文 140 Pages
概要

AI、リキッドバイオプシー、PET・CT・MRI技術の革新は、心臓血管科、神経科、腫瘍科における画像利用に変化をもたらす可能性を秘めています。

当レポートでは、技術的・臨床的ディスラプションの画像診断部門への影響を調査し、医用画像にディスラプションをもたらす潜在性を持つ各種技術の動向、医用画像にディスラプションをもたらす潜在性を秘めた臨床的動向、各種イメージングモダリティへのディスラプションの影響 (撮像件数への影響・予測)、成長機会・成功戦略の分析などをまとめています。

第1章 エグゼクティブサマリー

第2章 医用画像:概要

  • 市場概要:医用画像産業
  • 医用画像技術におけるディスラプション:概要

第3章 調査範囲・定義

第4章 医用画像にディスラプションをもたらす潜在性を持つ技術:AI

  • 技術概要・臨床性能
  • 各種専門領域における活用の潜在性
  • 疾患領域・クリニカルパスへの影響
  • 各種イメージングモダリティへの潜在的影響:撮像件数

第5章 医用画像にディスラプションをもたらす潜在性を持つ技術:精密医用画像

  • 技術概要・臨床性能
  • 各種専門領域における活用の潜在性
  • 臨床的利用
  • 各種イメージングモダリティへの潜在的影響:撮像件数

第6章 医用画像にディスラプションをもたらす潜在性を持つ技術:革新的トレーサー (放射性医薬品)

  • 技術概要・臨床性能
  • 心臓血管科における放射性医薬品
  • 腫瘍科における放射性医薬品
  • 各種イメージングモダリティへの潜在的影響:撮像件数

第7章 医用画像にディスラプションをもたらす潜在性を持つ技術:リキッドバイオプシー

  • 技術概要・臨床性能
  • 臨床的用途
  • リキッドバイオプシー:癌タイプ別
  • リキッドバイオプシー:癌のクリニカルパスへの影響
  • 各種イメージングモダリティへの潜在的影響:撮像件数

第8章 医用画像にディスラプションをもたらす潜在性を持つ技術:マイクロ波イメージング

  • 概要
  • 技術概要・臨床性能
  • 各種イメージングモダリティへの潜在的影響:撮像件数

第9章 医用画像にディスラプションをもたらす潜在性を持つ技術:脳磁図 (MEG)

  • 技術概要・臨床性能
  • 各種専門領域における活用の潜在性
  • 各種イメージングモダリティへの潜在的影響:撮像件数

第10章 医用画像にディスラプションをもたらす潜在性を持つ技術:軽度外傷性脳損傷 (MTBI) バイオマーカー

  • 技術概要・臨床性能
  • MTBIバイオマーカーのCTへの潜在的影響:撮像件数

第11章 医用画像にディスラプションをもたらす潜在性を秘めた臨床動向:心臓血管科

  • 心臓磁気共鳴
  • 冠動脈CT血管造影 (CCTA)
  • 経カテーテル心臓弁処置

第12章 医用画像にディスラプションをもたらす潜在性を秘めた臨床動向:神経科

  • 痴呆の画像撮像
  • パーキンソン病の画像撮像
  • 磁気共鳴血管造影:頭部・頸部

第13章 医用画像にディスラプションをもたらす潜在性を秘めた臨床動向:腫瘍科

  • 高濃度乳房の注意喚起

第14-21章 イメージングモダリティへのディスラプションの影響

  • 一般X線画像
  • インターベンショナルX線画像
  • X線マンモグラフィ
  • 超音波画像
  • CT画像
  • 磁気共鳴 (MR) 画像
  • PET/CT画像
  • SPECT/CT画像
    • 市場概要
    • 撮像件数:現在・予測
    • 撮像件数:専門分野別
    • X線画像に影響を及ぼす潜在的ディスラプション
    • ディスラプションの撮像件数への影響

第22章 成長機会・推奨行動

  • 成長機会:診断精度を向上させるマルチモダリティ画像
  • 成長機会:新興市場向けた製品/ソリューション
  • 成長機会:画像バリューチェーンの効率化のための新技術
  • 成長機会:臨床的適応症の拡大
  • 成功・成長の戦略的必須要件

第23章 総論

第24章 付録

第25章 FROST & SULLIVANについて

目次
Product Code: ME0A-50

AI, Liquid Biopsy, and Innovation in PET, CT, and MRI Techniques have the Potential to Recast Imaging in Cardiology, Neurology and Oncology

This growth insight report presents an analysis of the technological and clinical disruptions that are set to impact the global medical imaging industry. The healthcare industry is undergoing rapid changes catalyzed by innovative technologies, and the impact on the imaging industry is likely to be quite significant. Though emerging technologies such as AI and Precision Imaging reinforce the strength of imaging in the care pathway, other competing technologies such as microwave imaging and magnetoencephalography are set to pose a challenge in the long run. Imaging as an integral part of the care continuum is exposed to the vagaries of other factors in the ecosystem. A new surgical technique which demonstrates clinical evidence of superior outcome can increase the demand for interventional imaging procedures (e.g., TAVR, TMVR/r). Though technologies such as Coronary Computed Tomography Angiogrpahy (CCTA) have been available for a long time, the recent, mounting evidence of its clinical effectiveness is triggering higher adoption rates in clinical practice. On the other hand, innovation in non-imaging segments (e.g., liquid biopsy, blood-based biomarkers) is threatening the invincible status of imaging in oncology, neurology, and cardiology.

This report analyzes each modality and quantifies the number of procedures by application (by specialty). It further delves into the impact of each disruption on each modality by year and in terms of number of procedures. Incumbent imaging leaders have to strategize for the future with these disruptions in consideration which can in turn impact their product development, engineering, production, and marketing aspects of the business.

Growth opportunities for the imaging industry, in the face of disruptions, are identified and discussed to enable the industry to strategize their growth plans. The base year for the study is 2017, with 2018 to 2022 as forecast period for procedure volumes.

Research Scope:

  • Modalities covered: general X-ray, interventional X-ray, X-ray mammography, ultrasound, CT, MRI, PET/CT, SPECT/CT
  • Procedure volume trends by modality and by region
  • Procedure breakup (%) by specialty of each modality
  • Level of impact of disruptions relevant to the modality
  • Impact of disruptions quantified by procedure volumes by modality by year
  • Geographies covered: US, EU5 (Germany, France, Italy, Spain, UK), Japan, and Rest of World

Table of Contents

1. EXECUTIVE SUMMARY

  • Executive Summary
  • Disruptions in Medical Imaging Due to New Technologies, Global, 2017-2022
  • Disruptions in Medical Imaging Due to New Clinical Trends, Global, 2017-2022
  • Key Findings
  • Key Findings (continued)
  • Key Findings (continued)
  • Key Findings (continued)

2. MEDICAL IMAGING OVERVIEW

  • Market Snapshot-Medical Imaging Industry
  • Overview of Disruptions in Medical Imaging Technology

3. STUDY SCOPE AND DEFINITIONS

  • Study Scope and Definitions
  • Terms and Abbreviations
  • Methodology
  • Key Questions this Study will Answer

4. TECHNOLOGIES WITH THE POTENTIAL TO DISRUPT MEDICAL IMAGING-ARTIFICIAL INTELLIGENCE

  • Overview of Technology and Clinical Performance
  • Potential Utilization in Various Specialties
  • Impact on Disease Areas and Clinical Care Pathway
  • Potential Impact on Various Imaging Modalities (Procedure Volumes)

5. PRECISION IMAGING

  • Overview of Technology and Clinical Performance
  • Potential Utilization in Various Specialties
  • Clinical Utility of Precision Imaging
  • Potential Impact on Various Imaging Modalities (Procedure Volumes)

6. INNOVATIVE RADIOPHARMACEUTICAL TRACERS

  • Overview of Technology and Clinical Performance
  • Innovative Radiopharmaceuticals in Cardiology
  • Innovative Radiopharmaceuticals in Oncology
  • Potential Impact on Various Imaging Modalities (Procedure Volumes)

7. LIQUID BIOPSY

  • Overview of Technology and Clinical Performance
  • Clinical Applications of Liquid Biopsy
  • Liquid Biopsy by Cancer Type
  • Liquid Biopsy by Cancer Type (continued)
  • Oncology Clinical Care Pathway Impacted by Liquid Biopsy
  • Potential Impact on Various Imaging Modalities (Procedure Volumes)

8. MICROWAVE IMAGING

  • Overview
  • Technology and Clinical Performance
  • Potential Impact on Various Imaging Modalities (Procedure Volumes)

9. MAGNETOENCEPHALOGRAPHY

  • Magnetoencephalography Overview of Technology and Clinical Performance
  • Potential Utilization in Various Specialties
  • Potential Impact on Various Imaging Modalities (Procedure Volumes)

10. MILD TRAUMATIC BRAIN INJURY (MTBI) BIOMARKER

  • Overview of Technology and Clinical Performance
  • mTBI Biomarker Potential Impact on CT (Procedure Volumes)

11. CLINICAL TRENDS WITH THE POTENTIAL TO DISRUPT MEDICAL IMAGING-CARDIOLOGY

  • Cardiac Magnetic Resonance
  • Coronary Computed Tomography Angiography (CCTA)
  • Transcatheter Heart Valve Procedures

12. NEUROLOGY

  • Dementia Imaging
  • Parkinson's Disease Imaging
  • Magnetic Resonance Angiography-Head & Neck

13. ONCOLOGY

  • Dense Breast Notification

14. IMPACT OF DISRUPTIONS ON IMAGING MODALITIES-GENERAL X-RAY IMAGING

  • Market Overview
  • Global X-ray Imaging Volume-Current and Forecast
  • Global X-ray Imaging Volume by Specialty
  • Potential Disruptions Impacting X-ray Utilization
  • Impact of Disruptions on the Global X-ray Imaging Volume

15. INTERVENTIONAL X-RAY (IXR) IMAGING

  • Market Overview
  • Global Interventional X-ray Procedure Volumes-Current and Forecast
  • Global Interventional X-ray Procedure Volumes by Specialty
  • Potential Disruption Impacting Interventional X-ray Utilization
  • Impact of Disruptions on the Global IXR Procedure Volumes

16. X-RAY MAMMOGRAPHY

  • Market Overview
  • Global X-ray Mammography Volumes-Current and Forecast
  • Global X-ray Mammogram Volumes-Screening and Diagnostic Split
  • Potential Disruptions Impacting X-ray Mammography Utilization
  • Impact of Disruptions on the Global X-ray Mammogram Volumes

17. ULTRASOUND IMAGING

  • Market Overview
  • Global Ultrasound Imaging Volume-Current and Forecast
  • Global Ultrasound Imaging Volume by Specialty
  • Potential Disruptions Impacting Ultrasound Utilization
  • Impact of Disruptions on the Global Ultrasound Imaging Volume

18. COMPUTED TOMOGRAPHY (CT) IMAGING

  • Market Overview
  • Global CT Imaging Volume-Current and Forecast
  • Global CT Imaging Volume by Specialty
  • Potential Disruption Impacting CT Utilization
  • Impact of Disruptions on the Global CT Imaging Volume

19. MAGNETIC RESONANCE (MR) IMAGING

  • Market Overview
  • Global MR Imaging Volume-Current and Forecast
  • Global MR Imaging Volume by Specialty
  • Potential Disruption Impacting MRI Utilization
  • Impact of Disruptions on the Global MR Imaging Volume

20. POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/CT) IMAGING

  • Market Overview
  • Global PET/CT Imaging Volume-Current and Forecast
  • Global PET/CT Imaging Volume by Specialty
  • Potential Disruption Impacting PET/CT Utilization
  • Impact of Disruptions on the Global PET/CT Imaging Volume

21. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY/COMPUTED TOMOGRAPHY (SPECT/CT) IMAGING

  • Market Overview
  • Global SPECT/CT Imaging Volume-Current and Forecast
  • Global SPECT/CT Imaging Volume by Specialty
  • Potential Disruption Impacting SPECT/CT Utilization
  • Impact of Disruptions on the Global SPECT/CT Imaging Volume

22. GROWTH OPPORTUNITIES AND CALL TO ACTION

  • Growth Opportunity 1-Multimodality Imaging to Improve Diagnostic Accuracy
  • Growth Opportunity 2-Value Products/Solutions for Emerging Markets
  • Growth Opportunity 3-New Technologies to Ensure Efficiency of the Imaging Value Chain
  • Growth Opportunity 4-Clinical Indication Expansion
  • Strategic Imperatives for Success and Growth

23. THE LAST WORD

  • Three Big Predictions
  • Legal Disclaimer

24. APPENDIX

  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)

25. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top